(RTTNews) – Dr. Reddy’s Laboratories Ltd. (RDY) announced Thursday night the launch of Venlafaxine ER tablets in the United States.
The antidepressant drug is therapeutically for Osmotica Pharmaceutical US LLC’s 150 mg and 225 mg venlafaxine extended-release tablets. USA
Dr. Reddy’s Venlafaxine ER tablets are obtained in doses of 150 mg and 225 mg in vials of 30 and 90.
According to IQVIA Health, the logo and generic made sales in the U. S. UU. De approximately $51 million during the twelve months ending in October 2021.